CD4 and breast cancer: Significantly reduced MDSCs accumulation and increased the proportion of CD4+ and CD8+ T cells in the spleen and tumor sites of 4T1 BC mice through the Arg-1/iNOS/Nox2/NF-κB/STAT3 signaling pathway